Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy

por Schmitz, M, Temme, A, Senner, V, Ebner, R, Schwind, S, Stevanovic, S, Wehner, R, Schackert, G, Schackert, H K, Fussel, M, Bachmann, M, Rieber, E P, Weigle, B
Publicado 2007

Ovarian cancer in younger vs older women: a population-based analysis

por Chan, J K, Urban, R, Cheung, M K, Osann, K, Husain, A, Teng, N N, Kapp, D S, Berek, J S, Leiserowitz, G S, Shin, J Y
Publicado 2007

Cellular senescence and chromatin organisation

por Narita, M
Publicado 2007

Interpretation of microarray data in cancer

por Michiels, S, Koscielny, S, Hill, C
Publicado 2007

Ovarian cancer in younger vs older women: a population-based analysis

por Chan, J K, Urban, R, Cheung, M K, Osann, K, Shin, J Y, Husain, A, Teng, N N, Kapp, D S, Berek, J S, Leiserowitz, G S
Publicado 2007

Birth weight in relation to endometrial and breast cancer risks in Swedish women

por Löf, M, Sandin, S, Hilakivi-Clarke, L, Weiderpass, E
Publicado 2007

Increasing incidence of childhood leukaemia: a controversy re-examined

por Shah, A, Coleman, M P
Publicado 2007

GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours

por Shamash, J, Powles, T, Ansell, W, Berney, D, Stebbing, J, Mutsvangwa, K, Wilson, P, Asterling, S, Liu, S, Wyatt, P, Joel, S P, Oliver, R T D
Publicado 2007

Cigarette smoking and breast cancer risk: a population-based study in Sweden

por Magnusson, C, Wedrén, S, Rosenberg, L U
Publicado 2007

Absence of p300 induces cellular phenotypic changes characteristic of epithelial to mesenchyme transition

por Krubasik, D, Iyer, N G, English, W R, Ahmed, A A, Vias, M, Roskelley, C, Brenton, J D, Caldas, C, Murphy, G
Publicado 2006

Reply: Familial ovarian screening: how to address abnormal TVU findings and its influence on the efficacy of screening?

por Oei, A L M, Massuger, L F A G, Bulten, J, Ligtenberg, M J L, Hoogerbrugge, N, de Hullu, J A
Publicado 2006

Stressful life events and cancer risk

por Bergelt, C, Prescott, E, Grønbæk, M, Koch, U, Johansen, C
Publicado 2006

The telomeric PARP, tankyrases, as targets for cancer therapy

por Seimiya, H
Publicado 2006

Reply: Her2 (ErbB2) receptors, a potential therapeutic target in squamous cell carcinoma of oesophagus?

por Metges, J-P, Gibault, L, Conan-Charlet, V, Lozac'H, P, Robaszkiewicz, M, Bessaguet, C, Lagarde, N, Volant, A
Publicado 2006

Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy

por Manton, D J, Chaturvedi, A, Hubbard, A, Lind, M J, Lowry, M, Maraveyas, A, Pickles, M D, Tozer, D J, Turnbull, L W
Publicado 2006

Reply: Increased risk of breast cancer among female relatives of patients with Ataxia-Telangiectasia: a causal relationship?

por Olsen, J H, Hahnemann, J M D, Børresen-Dale, A-L, Tretli, S, Kleinerman, R, Sankila, R, Hammarström, L, Robsahm, T E, Kääriäinen, H, Bregård, A, Brøndum-Nielsen, K, Yuen, J, Tucker, M
Publicado 2005

Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer

por Sobrero, A, Frassineti, G, Falcone, A, Dogliotti, L, Rosso, R, Di Costanzo, F, Bruzzi, P
Publicado 2005

Increased risk of breast cancer among female relatives of patients with ataxia-telangiectasia: a causal relationship?

por d'Almeida, A K, Cavaciuti, E, Dondon, M-G, Laugé, A, Janin, N, Stoppa-Lyonnet, D, Andrieu, N
Publicado 2005

Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients

por Tonini, G, Vincenzi, B, Santini, D, Scarpa, S, Vasaturo, T, Malacrino, C, Coppola, R, Magistrelli, P, Borzomati, D, Baldi, A, Antinori, A, Caricato, M, Nuzzo, G, Picciocchi, A
Publicado 2005

The role of S-1 in the treatment of gastric cancer

por Kubota, T
Publicado 2008